CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4

Mol Psychiatry. 2014 Feb;19(2):148-9. doi: 10.1038/mp.2013.18. Epub 2013 Feb 19.

¹ Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
² UCL Institute of Neurology, London, UK.
³ Clinical Memory Research Unit, Clinical Sciences Malmö, Lund University, Lund, Sweden.
⁴ Department of Neurology and Brain Research Unit, Clinical Research Centre/Mediteknia, University of Eastern Finland, Kuopio, Finland.
⁵ Institute for Stroke and Dementia Research (ISD), Ludwig-Maximilians-University, Munich, Germany.
⁶ Department of Psychiatry, Goethe University, Frankfurt, Germany.
⁷ 1] Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden [2] UCL Institute of Neurology, London, UK.

No abstract available

Publication types